Signal2026-07-16
ClinicalTrials.gov

[PHASE1] Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease

Part of

Evolving Gene Therapy Research Oversight

Open primary sourceSee the whole picture